These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17254505)

  • 1. Wolbachia in filarial parasites: targets for filarial infection and disease control.
    Johnston KL; Taylor MJ
    Curr Infect Dis Rep; 2007 Jan; 9(1):55-9. PubMed ID: 17254505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wolbachia filarial interactions.
    Taylor MJ; Voronin D; Johnston KL; Ford L
    Cell Microbiol; 2013 Apr; 15(4):520-6. PubMed ID: 23210448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The symbiotic role of Wolbachia in Onchocercidae and its impact on filariasis.
    Bouchery T; Lefoulon E; Karadjian G; Nieguitsila A; Martin C
    Clin Microbiol Infect; 2013 Feb; 19(2):131-40. PubMed ID: 23398406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyruvate produced by Brugia spp. via glycolysis is essential for maintaining the mutualistic association between the parasite and its endosymbiont, Wolbachia.
    Voronin D; Schnall E; Grote A; Jawahar S; Ali W; Unnasch TR; Ghedin E; Lustigman S
    PLoS Pathog; 2019 Sep; 15(9):e1008085. PubMed ID: 31568486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wolbachia endosymbiotic bacteria of filarial nematodes. A new insight into disease pathogenesis and control.
    Taylor MJ
    Arch Med Res; 2002; 33(4):422-4. PubMed ID: 12234534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wolbachia bacterial endosymbionts of filarial nematodes.
    Taylor MJ; Bandi C; Hoerauf A
    Adv Parasitol; 2005; 60():245-84. PubMed ID: 16230105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wolbachia in filarial nematodes: evolutionary aspects and implications for the pathogenesis and treatment of filarial diseases.
    Bandi C; Trees AJ; Brattig NW
    Vet Parasitol; 2001 Jul; 98(1-3):215-38. PubMed ID: 11516587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Wolbachia endosymbiont as an anti-filarial nematode target.
    Slatko BE; Taylor MJ; Foster JM
    Symbiosis; 2010 Jul; 51(1):55-65. PubMed ID: 20730111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endosymbiotic Wolbachia of parasitic filarial nematodes as drug targets.
    Rao RU
    Indian J Med Res; 2005 Sep; 122(3):199-204. PubMed ID: 16251775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new approach to the treatment of filariasis.
    Taylor MJ; Hoerauf A
    Curr Opin Infect Dis; 2001 Dec; 14(6):727-31. PubMed ID: 11964892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wolbachia in the inflammatory pathogenesis of human filariasis.
    Taylor MJ
    Ann N Y Acad Sci; 2003 Jun; 990():444-9. PubMed ID: 12860672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-filarial activity of antibiotic therapy is due to extensive apoptosis after Wolbachia depletion from filarial nematodes.
    Landmann F; Voronin D; Sullivan W; Taylor MJ
    PLoS Pathog; 2011 Nov; 7(11):e1002351. PubMed ID: 22072969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corallopyronin A - a promising antibiotic for treatment of filariasis.
    Schäberle TF; Schiefer A; Schmitz A; König GM; Hoerauf A; Pfarr K
    Int J Med Microbiol; 2014 Jan; 304(1):72-8. PubMed ID: 24079981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward novel treatment against filariasis: Insight into genome-wide co-evolutionary analysis of filarial nematodes and
    Wangwiwatsin A; Kulwong S; Phetcharaburanin J; Namwat N; Klanrit P; Loilome W; Maleewong W; Reid AJ
    Front Microbiol; 2023; 14():1052352. PubMed ID: 37032902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wolbachia endosymbionts and human disease control.
    Slatko BE; Luck AN; Dobson SL; Foster JM
    Mol Biochem Parasitol; 2014 Jul; 195(2):88-95. PubMed ID: 25046729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphatic filariasis and onchocerciasis.
    Taylor MJ; Hoerauf A; Bockarie M
    Lancet; 2010 Oct; 376(9747):1175-85. PubMed ID: 20739055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AWZ1066S, a highly specific anti-
    Hong WD; Benayoud F; Nixon GL; Ford L; Johnston KL; Clare RH; Cassidy A; Cook DAN; Siu A; Shiotani M; Webborn PJH; Kavanagh S; Aljayyoussi G; Murphy E; Steven A; Archer J; Struever D; Frohberger SJ; Ehrens A; Hübner MP; Hoerauf A; Roberts AP; Hubbard ATM; Tate EW; Serwa RA; Leung SC; Qie L; Berry NG; Gusovsky F; Hemingway J; Turner JD; Taylor MJ; Ward SA; O'Neill PM
    Proc Natl Acad Sci U S A; 2019 Jan; 116(4):1414-1419. PubMed ID: 30617067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repurposing of approved drugs from the human pharmacopoeia to target Wolbachia endosymbionts of onchocerciasis and lymphatic filariasis.
    Johnston KL; Ford L; Umareddy I; Townson S; Specht S; Pfarr K; Hoerauf A; Altmeyer R; Taylor MJ
    Int J Parasitol Drugs Drug Resist; 2014 Dec; 4(3):278-86. PubMed ID: 25516838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue-specific transcriptomics and proteomics of a filarial nematode and its Wolbachia endosymbiont.
    Luck AN; Anderson KG; McClung CM; VerBerkmoes NC; Foster JM; Michalski ML; Slatko BE
    BMC Genomics; 2015 Nov; 16():920. PubMed ID: 26559510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and ultrastructural characterization of the Wolbachia symbiont in Litomosoides chagasfilhoi.
    Chagas-Moutinho VA; Silva R; de Souza W; Motta MC
    Parasit Vectors; 2015 Feb; 8():74. PubMed ID: 25649218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.